House Passes Bill To Lower Drug Prices, Bolster ACA
Law360 (May 17, 2019, 6:09 PM EDT) -- The U.S. House of Representatives passed legislation on Thursday that aims to lower prescription drug costs, including a bill that would ban pay-for-delay settlements to keep generic drugs off the market, as well as measures to strengthen the Affordable Care Act.
The full House voted 234-183 to approve the pay-for-delay ban and legislation known as the CREATES Act that would let generic-drug makers sue if branded drug companies don't provide them with samples needed to make their generic versions. Another measure approved Thursday would prevent drug companies from taking advantage of the exclusivity period to delay the approval of subsequent generics....
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!
Kirkland & Ellis LLP has redefined what it means to be the biggest of BigLaw — weighing in at 2,116 attorneys by year end 2018 and becoming the first firm since Law360 began tracking law firm head counts to top 2,000 U.S.-based attorneys.